Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02512016 · ClinicalTrials.gov registry record · NA

Motherhood and Pelvic Health (MAP Study)

A NA study, sponsored by University of Utah.

Completed
Registry status
NA
Development phase
1,079
Enrollment target

NCT02512016: Completed NA study, sponsored by University of Utah.

NCT02512016 is a NA study that has completed, run by University of Utah. The registered enrollment target is 1,079 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02512016, a NA study, has completed, sponsored by University of Utah.

COMPLETED
Registry status
NA
Development phase
1,079 participants
Enrollment target

Study Summary

The Motherhood and Pelvic health study (MAP), Bridging physical and cultural determinants of postpartum pelvic floor support and symptoms following vaginal delivery, uses mixed methods research to study the influences of intra-abdominal pressure, physical activity and strength on pelvic floor support and symptoms and the cultural context in which women experience those changes.

Primary Outcome

Assessed using the Pelvic Organ Prolapse Quantification examination, categorized into maximum vaginal descent at or below the hymen (\>/= 0 cm) versus above the hymen (\< 0 cm)

Interventions

  • OTHER Study Procedures

Trial Details

FieldValue
Enrollment Target 1,079 participants
Start Date 2015-08
Est. Completion 2020-08-15
Phase NA
University of Utah

818 total trials

What the finished NCT02512016 record still lists

NCT02512016 is an interventional study that assigns participants to a tested intervention. Its 1,079 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (23% lower).

The record links to 0 conditions, and to 1 intervention - of which Study Procedures is the first listed.

NCT02512016 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02512016 about?

NCT02512016 is a clinical study titled "Motherhood and Pelvic Health (MAP Study)". The Motherhood and Pelvic health study (MAP), Bridging physical and cultural determinants of postpartum pelvic floor support and symptoms following vaginal delivery, uses mixed methods research to study the influences of intra-abdominal pressure, physical activity and strength on pelvic floor suppor...

What is the current status of trial NCT02512016?

This trial is currently completed. It is a NA study. The enrollment target is 1,079 participants. The study started on 2015-08. Estimated completion is 2020-08-15.

What interventions are being tested in trial NCT02512016?

The interventions under investigation include: Study Procedures (OTHER).

Who is sponsoring clinical trial NCT02512016?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02512016's enrollment target sits among peer trials

1,079 95th of 2000 higher than 1,906 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06074068 · 1,080 participants · NA

    Father-Focused Intervention for Reducing Family Violence and Symptoms in Children

  • NCT07213804 · 1,080 participants · Phase 3

    A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer

  • NCT07084883 · 1,076 participants

    Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration

  • NCT06658808 · 1,075 participants · NA

    Efficacy-Implementation Study for PC CARES in Rural Alaska

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02512016, the US trial registry maintained by the National Library of Medicine. NCT02512016 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.